Khloé Kardashian is back again to promote Biohaven migraine med Nurtec ODT in its newest TV and digital campaign (courtesy Biohaven)

July 18, 2022 02:02 PM EDTUpdated 04:45 PM

Marketing

Khloé Kardashian strikes again with migraine med Nurtec marketing in ‘all in one’ push

Beth Snyder Bulik

Senior Editor

Reality star, businesswoman and brand boss Khloé Kardashian is back on TV for Biohaven’s migraine brand Nurtec ODT. The mega-influencer is leading the charge for …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

Khloé Kardashian strikes again with migraine med Nurtec marketing in ‘all in one’ push

Beth Snyder Bulik

Senior Editor

Sign up to read this article for free.

Three drugmakers sue US over 340B discounts to STD clinics they allege don’t qualify

CagriSema’s weight loss data disappointed. What does Novo do next?

FDA approves Lilly's Zepbound for sleep apnea, likely cracking open Medicare market

CMS explains what went into its first round of drug price negotiations

Deerfield wins fight to acquire Singular Genomics, beating out Tang Capital’s Concentra

Vertex gets 'vanza triple' approval and Trikafta expansion — with boxed warnings

Khloé Kar­dashi­an strikes again with mi­graine med Nurtec mar­ket­ing in ‘all in one’ push

Beth Snyder Bulik

Senior Editor

Sign up to read this article for free.

more like this

Three drug­mak­ers sue US over 340B dis­counts to STD clin­ics they al­lege don’t qual­i­fy

Ca­griSe­ma’s weight loss da­ta dis­ap­point­ed. What does No­vo do next?

FDA ap­proves Lil­ly's Zep­bound for sleep ap­nea, like­ly crack­ing open Medicare mar­ket

CMS ex­plains what went in­to its first round of drug price ne­go­ti­a­tions

Deer­field wins fight to ac­quire Sin­gu­lar Ge­nomics, beat­ing out Tang Cap­i­tal’s Con­cen­tra

Ver­tex gets 'van­za triple' ap­proval and Trikaf­ta ex­pan­sion — with boxed warn­ings

Khloé Kardashian strikes again with migraine med Nurtec marketing in ‘all in one’ push

Three drugmakers sue US over 340B discounts to STD clinics they allege don’t qualify

CagriSema’s weight loss data disappointed. What does Novo do next?

FDA approves Lilly's Zepbound for sleep apnea, likely cracking open Medicare market

CMS explains what went into its first round of drug price negotiations

Deerfield wins fight to acquire Singular Genomics, beating out Tang Capital’s Concentra

Vertex gets 'vanza triple' approval and Trikafta expansion — with boxed warnings